Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
2022

Share:

Neurophet AQUA

Medical diagnostic solution

NEUROPHET, Inc.

NEUROPHET AQUA is a medical AI solution for the diagnosis of dementia. AQUA helps doctors detect structural changes in the brain early before dementia occurs. This allows patients to receive appropriate treatment at the right time. Through AI algorithms, AQUA can detect quantitative changes in the brain that cannot be visually grasped from an MRI. Most medical solutions are slow, difficult, and complex. However, AQUA simplified and automated all these processes, greatly reducing the time users spend on analysis. AQUA helps medical staff diagnose dementia more efficiently so they can provide care to patients.

Date of Launch
2021
Development Time
13 - 24 months
Target Regions
Asia, Europe, North America
Target Groups
Consumer / User, Trade / Industry, Specific sub-group: Doctor, Medical staff, Senior patients

RELATED PROJECTS